A study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics (PD) of GSK3888130B in healthy participants

Trial Identifier:	213960
Sponsor:	GlaxoSmithKline
Collaborator:	Not applicable
Start Date:	November 2021
Primary Completion Date:	October 2023
Study Completion Date:	October 2023
Condition:	Ulcerative Colitis; Multiple Sclerosis (MS)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Cambridge, United Kingdom, CB2 2GG

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.